[Federal Register Volume 65, Number 105 (Wednesday, May 31, 2000)]
[Notices]
[Pages 34707-34708]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-13506]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 00106]


World Health Organization for Hepatitis; Notice of Availability 
of Funds

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2000 funds for a cooperative agreement 
program for the World Health Organization (WHO) for hepatitis. CDC is 
committed to achieving the health promotion and disease prevention 
objectives of ``Healthy People 2010'', a national activity to reduce 
morbidity and mortality and improve the quality of life. This 
announcement is related to the focus areas of Immunization and 
Infectious Diseases. For the conference copy of ``Healthy People 
2010'', visit the internet site http://www.health.gov/healthypeople.
    The purpose of this cooperative agreement is to develop 
international programs for prevention and control of hepatitis A 
through immunization, hepatitis B immunization activities as part of 
national immunization programs of member states, supporting programs to 
prevent transmission of bloodborne hepatitis virus infections through 
unsafe injection and infection control practices, improving injection 
safety, and preventing transmission of hepatitis C virus (HCV) 
infections.

B. Eligible Applicants

    Assistance will be provided only to the WHO. No other applications 
are solicited.
    The WHO is the most appropriate and qualified agency to conduct the 
activities specified under this cooperative agreement because:
    1. They are the only organization with the worldwide mandate to 
assist member nations in the control and prevention of vaccine 
preventable diseases.
    2. They are responsible for implementation of the Expanded 
Programme on Immunization (EPI) and for the introduction of hepatitis B 
vaccine into the EPI of member states as stated by resolution of the 
World Health Assembly in 1992.
    3. They are the only recognized international organization for 
providing the guidance and leadership needed to coordinate the 
multidisciplinary collaborations required to address elimination of 
unsafe injection, have an established activity to address this issue 
and serves as the secretariat for the Safe Injection Global Network 
(SIGN), a collaborative network comprised of member states and 
organizations.
    4. They are the only recognized international organization to 
provide the guidance and leadership needed to coordinate the 
multidisciplinary collaborations required to address the control of 
hepatitis C virus infection and its chronic liver disease consequences 
and has an established activity to address this issue in their emerging 
infections program.
    5. The proposed program is directly related to the achievement of 
WHO and the National Center for Infectious Diseases, CDC, objectives 
for the control and prevention of viral hepatitis, including hepatitis 
A, B, and C.

C. Availability of Funds

    Approximately $300,000 is available in FY 2000 to fund this award. 
It is expected the award will begin on September 29, 2000, and will be 
made for a 12-month budget period within a project period of up to 
three years. The funding estimate may change.
    A continuation award within an approved project period will be made 
on the basis of satisfactory progress as evidenced by required reports 
and the availability of funds.

[[Page 34708]]

D. Where To Obtain Additional Information

    This and other Centers for Disease Control announcements can be 
found on the Centers for Disease Control home page Internet address--
http://www.cdc.gov Click on ``Funding'' then ``Grants and Cooperative 
Agreements''.
    To obtain additional information, contact: Oppie Byrd, Grants 
Management Specialist, Grants Management Branch, Procurement and Grants 
Office, Centers for Disease Control and Prevention, Room 3000, 2920 
Brandywine Road, Atlanta, GA 30341-4146, Telephone: (770) 488-2748, E-
mail address: [email protected].
    For program technical assistance, contact: Richard Conlon, Centers 
for Disease Control and Prevention, National Center for Infectious 
Diseases, Division of Rickettsial Diseases, Hepatitis Branch, 1600 
Clifton Road, NE, M/S G-37, Atlanta, GA 30333, Telephone: (404)371-
5900, E-mail address: [email protected].

    Dated: May 24, 2000.
John L. Williams,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention (CDC).
[FR Doc. 00-13506 Filed 5-30-00; 8:45 am]
BILLING CODE 4163-18-P